141 related articles for article (PubMed ID: 36150451)
21. Corylifol A ameliorates muscle atrophy by inhibiting TAOK1/p38-MAPK/FoxO3 pathway in cancer cachexia.
Zhang R; Shen Q; Wang Y; Deng X; Fan J; Gu X; Fan M; Wei K; Cheng CR; Zhang WD; Zhang XW; Liu X
J Cachexia Sarcopenia Muscle; 2023 Oct; 14(5):2098-2113. PubMed ID: 37439183
[TBL] [Abstract][Full Text] [Related]
22. MiR-96-5p Induced by Palmitic Acid Suppresses the Myogenic Differentiation of C2C12 Myoblasts by Targeting FHL1.
Nguyen MT; Min KH; Lee W
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322515
[TBL] [Abstract][Full Text] [Related]
23. Magnolol inhibits myotube atrophy induced by cancer cachexia through myostatin signaling pathway in vitro.
Ge Z; Liu D; Shang Y; Li Y; Chen SZ
J Nat Med; 2020 Sep; 74(4):741-749. PubMed ID: 32601830
[TBL] [Abstract][Full Text] [Related]
24. Systemic effect of FHL1 on neuromuscular junction and myotube formation via insulin-like growth factor and myostatin signaling pathways.
Wu J; Zhao K; Du Z; Chen Y; Zhang F; Jiang W; Zheng J; Wu X; Shen C; Xiao X
Biochem Biophys Res Commun; 2021 Jan; 537():125-131. PubMed ID: 33401146
[TBL] [Abstract][Full Text] [Related]
25. Extracellular vesicles derived from tumour cells as a trigger of energy crisis in the skeletal muscle.
Pin F; Beltrà M; Garcia-Castillo L; Pardini B; Birolo G; Matullo G; Penna F; Guttridge D; Costelli P
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):481-494. PubMed ID: 34931471
[TBL] [Abstract][Full Text] [Related]
26. Development of a traditional Chinese medicine-based agent for the treatment of cancer cachexia.
Wu KC; Chu PC; Cheng YJ; Li CI; Tian J; Wu HY; Wu SH; Lai YC; Kao HH; Hsu AL; Lin HW; Lin CH
J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2073-2087. PubMed ID: 35718751
[TBL] [Abstract][Full Text] [Related]
27. The green tea polyphenol epigallocatechin-3-gallate attenuates age-associated muscle loss via regulation of miR-486-5p and myostatin.
Chang YC; Liu HW; Chan YC; Hu SH; Liu MY; Chang SJ
Arch Biochem Biophys; 2020 Oct; 692():108511. PubMed ID: 32710883
[TBL] [Abstract][Full Text] [Related]
28. Compound Z526 alleviates chemotherapy-induced cachectic muscle loss by ameliorating oxidative stress-driven protein metabolic imbalance and apoptosis.
Gu X; Lu S; Fan M; Xu S; Lin G; Zhao Y; Zhao W; Liu X; Dong X; Zhang X
Eur J Pharmacol; 2024 Jul; 974():176538. PubMed ID: 38552940
[TBL] [Abstract][Full Text] [Related]
29. Ginsenoside Rd ameliorates muscle wasting by suppressing the signal transducer and activator of transcription 3 pathway.
Wijaya YT; Setiawan T; Sari IN; Park K; Lee CH; Cho KW; Lee YK; Lim JY; Yoon JK; Lee SH; Kwon HY
J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):3149-3162. PubMed ID: 36127129
[TBL] [Abstract][Full Text] [Related]
30. Protective effects of Liuwei dihuang water extracts on diabetic muscle atrophy.
Tseng YT; Chang WH; Lin CC; Chang FR; Wu PC; Lo YC
Phytomedicine; 2019 Feb; 53():96-106. PubMed ID: 30668418
[TBL] [Abstract][Full Text] [Related]
31. Flavones Inhibit LPS-Induced Atrogin-1/MAFbx Expression in Mouse C2C12 Skeletal Myotubes.
Shiota C; Abe T; Kawai N; Ohno A; Teshima-Kondo S; Mori H; Terao J; Tanaka E; Nikawa T
J Nutr Sci Vitaminol (Tokyo); 2015; 61(2):188-94. PubMed ID: 26052151
[TBL] [Abstract][Full Text] [Related]
32. Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice.
Kandarian SC; Nosacka RL; Delitto AE; Judge AR; Judge SM; Ganey JD; Moreira JD; Jackman RW
J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1109-1120. PubMed ID: 30270531
[TBL] [Abstract][Full Text] [Related]
33. Proteomics analysis of C2C12 myotubes treated with atrophy inducing cancer cell-derived factors.
Marzan AL; Chitti SV; Gummadi S; Kang T; Ang CS; Mathivanan S
Proteomics; 2024 Jun; 24(11):e2300020. PubMed ID: 37882347
[TBL] [Abstract][Full Text] [Related]
34. IL-17A contributes to skeletal muscle atrophy in lung cancer-induced cachexia via JAK2/STAT3 pathway.
Ying L; Yao Y; Lv H; Lu G; Zhang Q; Yang Y; Zhou J
Am J Physiol Cell Physiol; 2022 May; 322(5):C814-C824. PubMed ID: 35319902
[TBL] [Abstract][Full Text] [Related]
35. Sulforaphane prevents dexamethasone-induced muscle atrophy via regulation of the Akt/Foxo1 axis in C2C12 myotubes.
Son YH; Jang EJ; Kim YW; Lee JH
Biomed Pharmacother; 2017 Nov; 95():1486-1492. PubMed ID: 28946211
[TBL] [Abstract][Full Text] [Related]
36. Oncostatin M induces C2C12 myotube atrophy by modulating muscle differentiation and degradation.
Miki Y; Morioka T; Shioi A; Fujimoto K; Sakura T; Uedono H; Kakutani Y; Ochi A; Mori K; Shoji T; Emoto M; Inaba M
Biochem Biophys Res Commun; 2019 Aug; 516(3):951-956. PubMed ID: 31272716
[TBL] [Abstract][Full Text] [Related]
37. GDF-15 in tumor-derived exosomes promotes muscle atrophy via Bcl-2/caspase-3 pathway.
Zhang W; Sun W; Gu X; Miao C; Feng L; Shen Q; Liu X; Zhang X
Cell Death Discov; 2022 Apr; 8(1):162. PubMed ID: 35379793
[TBL] [Abstract][Full Text] [Related]
38. BMSC-Derived Exosomes Inhibit Dexamethasone-Induced Muscle Atrophy
Li Z; Liu C; Li S; Li T; Li Y; Wang N; Bao X; Xue P; Liu S
Front Endocrinol (Lausanne); 2021; 12():681267. PubMed ID: 34659106
[TBL] [Abstract][Full Text] [Related]
39. Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression.
Wu Q; Sun S; Li Z; Yang Q; Li B; Zhu S; Wang L; Wu J; Yuan J; Yang C; Li J; Sun S
Mol Cancer; 2018 Oct; 17(1):155. PubMed ID: 30359265
[TBL] [Abstract][Full Text] [Related]
40. Coculture with Colon-26 cancer cells decreases the protein synthesis rate and shifts energy metabolism toward glycolysis dominance in C2C12 myotubes.
Tamura Y; Kouzaki K; Kotani T; Nakazato K
Am J Physiol Cell Physiol; 2024 May; 326(5):C1520-C1542. PubMed ID: 38557354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
